Eli Lilly CDR (CAD Hedged)
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 43K
- Market Cap
- $859.4B
- Introduction
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
A Study of Olaratumab in Soft Tissue Sarcoma
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2017-04-14
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 148
- Registration Number
- NCT01185964
- Locations
- 🇺🇸
ImClone Investigational Site, Madison, Wisconsin, United States
A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy
- Conditions
- Arthritis, Rheumatoid
- Interventions
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 301
- Registration Number
- NCT01185353
- Locations
- 🇺🇦
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Vinnytsya, Ukraine
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2018-04-27
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 1056
- Registration Number
- NCT01185340
- Locations
- 🇬🇧
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chesterfield, United Kingdom
A Study in Migraine Prevention
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2018-09-12
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 87
- Registration Number
- NCT01184508
- Locations
- 🇵🇷
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Juan, Puerto Rico
A Study in Second Line Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2010-08-18
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 1072
- Registration Number
- NCT01183780
- Locations
- 🇨🇳
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taipei, Taiwan
A Study of Tadalafil in Benign Prostatic Hyperplasia
- First Posted Date
- 2010-08-17
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 24
- Registration Number
- NCT01183650
- Locations
- 🇩🇪
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Munich, Germany
A Study in Participants With Diabetic Peripheral Neuropathic Pain in China
- First Posted Date
- 2010-08-11
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 405
- Registration Number
- NCT01179672
- Locations
- 🇨🇳
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Yueyang, China
An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults
- First Posted Date
- 2010-08-09
- Last Posted Date
- 2012-02-15
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 26
- Registration Number
- NCT01178099
- Locations
- 🇬🇧
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, UK, United Kingdom
A Bioequivalence (BE) Study in Healthy Subjects
- First Posted Date
- 2010-08-09
- Last Posted Date
- 2011-10-27
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 42
- Registration Number
- NCT01177943
- Locations
- 🇯🇵
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fukuoka, Japan
Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2010-08-05
- Last Posted Date
- 2014-02-24
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 478
- Registration Number
- NCT01175824
- Locations
- 🇹🇷
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Istanbul, Turkey